Neurogene Inc’s filing revealed that its President and CFO Cvijic Christine Mikail acquired Company’s shares for reported $0.49 million on Nov 22 ’24. In the deal valued at $20.48 per share,24,000 shares were bought. As a result of this transaction, Cvijic Christine Mikail now holds 76,844 shares worth roughly $1.72 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, McMinn Rachel bought 47,500 shares, generating $969,000 in total proceeds. Upon buying the shares at $20.40, the Chief Executive Officer now owns 1,297,859 shares.
BMO Capital Markets initiated its Neurogene Inc [NGNE] rating to an Outperform in a research note published on June 27, 2024; the price target was $65. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in mid June with a ‘”an Outperform”‘ rating. Leerink Partners began covering NGNE with “an Outperform” recommendation on April 29, 2024. William Blair started covering the stock on March 21, 2024. It rated NGNE as “an Outperform”.
Price Performance Review of NGNE
On Monday, Neurogene Inc [NASDAQ:NGNE] saw its stock jump 9.93% to $22.32. Over the last five days, the stock has gained 12.59%. Neurogene Inc shares have risen nearly 15.14% since the year began. Nevertheless, the stocks have risen 57.59% over the past one year. While a 52-week high of $74.49 was reached on 11/11/24, a 52-week low of $12.49 was recorded on 11/21/24. SMA at 50 days reached $44.56, while 200 days put it at $38.73.
Levels Of Support And Resistance For NGNE Stock
The 24-hour chart illustrates a support level at 21.02, which if violated will result in even more drops to 19.73. On the upside, there is a resistance level at 23.09. A further resistance level may holdings at 23.87. The Relative Strength Index (RSI) on the 14-day chart is 34.68, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -18.96, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.88%. Stochastics %K at 8.27% indicates the stock is a buying.
How much short interest is there in Neurogene Inc?
A steep rise in short interest was recorded in Neurogene Inc stocks on 2024-10-31, dropping by -0.98 million shares to a total of 0.91 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 1.9 million shares. There was a decline of -107.49%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 08, 2024 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $45 price target.
